PRICE T ROWE ASSOCIATES INC /MD/ - ONCOCYTE CORP ownership

ONCOCYTE CORP's ticker is OCX and the CUSIP is 68235C107. A total of 90 filers reported holding ONCOCYTE CORP in Q4 2021. The put-call ratio across all filers is 0.19 and the average weighting 0.1%.

Quarter-by-quarter ownership
PRICE T ROWE ASSOCIATES INC /MD/ ownership history of ONCOCYTE CORP
ValueSharesWeighting
Q3 2022$27,000
-18.2%
36,6000.0%0.00%
Q2 2022$33,000
-46.8%
36,600
-12.0%
0.00%
Q1 2022$62,000
+5.1%
41,578
+53.5%
0.00%
Q4 2021$59,000
-43.3%
27,078
-6.9%
0.00%
Q3 2021$104,000
-37.3%
29,078
+0.7%
0.00%
Q2 2021$166,000
-32.2%
28,878
-38.9%
0.00%
Q1 2021$245,00047,2730.00%
Other shareholders
ONCOCYTE CORP shareholders Q4 2021
NameSharesValueWeighting ↓
BROADWOOD CAPITAL INC 17,349,945$61,766,0003.15%
Defender Capital, LLC. 1,960,820$6,935,0002.26%
Millrace Asset Group, Inc. 613,885$2,185,0001.36%
PURA VIDA INVESTMENTS, LLC 12,223,953$43,517,0001.32%
Penbrook Management LLC 577,200$2,055,0001.28%
ACT CAPITAL MANAGEMENT, LLC 330,000$1,175,0000.61%
AWM Investment Company, Inc. 717,000$2,553,0000.25%
Colonial River Wealth Management, LLC 66,200$218,0000.15%
CALIBER WEALTH MANAGEMENT, LLC 66,200$218,0000.15%
Fort Sheridan Advisors LLC 110,000$392,0000.13%
View complete list of ONCOCYTE CORP shareholders